NCT05667506 - A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 7, 2023

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2027

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL

single dose of CNCT19

"Autologous 2nd generation CD19-directed CAR-T cells, single infusion intravenously.~Lymphodepletion treatment:~Drugs:Fludarabine Drugs: Cyclophosphamide"

Trial Locations (9)

Unknown

NOT_YET_RECRUITING

The Second Hospital of Anhui Medical University, Hefei

RECRUITING

Children's Hospital of Chongqing Medical University, Chongqing

RECRUITING

Guangzhou Women and Children's Medical Center, Guangzhou

NOT_YET_RECRUITING

Nanfang Hospital, Guangzhou

NOT_YET_RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science of Technology, Wuhan

RECRUITING

Children's Hospital of Nanjing Medical University, Nanjing

RECRUITING

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

RECRUITING

The First Affilicated Hospital of Nanchang University, Nanchang

RECRUITING

Institute of Hematology & Blood Diseases Hospital, Tianjin